retested 2-6 weeks later. 48 infants had transient hypermethioninaemia of at least 3 weeks' duration, one had a more persistent form associated with abnormal liver function tests, 3 had different forms of homocystinuria, and one infant, who was asymptomatic at the time of detection, had hypermethioninaemia associated with a rapidly fatal form of tyrosinaemia (tyrosinosis). Two infants could not be followed up. Transient hypermethioninaemia has not been detected in this laboratory since 1975 . There was a greatly reduced incidence of transient hypermethioninaemia in girls after 1972 and in boys after 1975; this may have been due to recent changes in infant feeding practices in the UK. Homocystinuria was last detected in this laboratory in 1972; the apparent change in incidence is significant (P<0 .05) and suggests that the diagnostic value of this screening procedure should be reassessed.
Neonatal screening for homocystinuria on a national scale is not yet acceptable because of the apparent low incidence of the disease, the uncertainty about the reliability of methods of screening, and about the long-term efficacy of current methods of treatment. Results from different screening centres suggest that the incidence of homocystinuria varies considerably from one area to another, but the extent to which this reflects a true difference in the incidence of the disease or a difference in methodology has been questioned (Thalhammer, 1975; Wilcken and Turner, 1978) . Classical homocystinuria can be accompanied by hypermethioninaemia in the neonatal period (Komrower et al., 1966) and this finding forms the basis of one simple screening procedure (Guthrie, 1968 (Mudd et al., 1970 (Mudd et al., , 1972 and may sometimes be absent in classical homocystinuria in the first days of life (Komrower et al., 1966; Levy et al., 1971) .
Transient hypermethioninaemia in the neonatal period has been associated with a high protein intake and, in premature infants at least, a low hepatic cystathioninase activity may be a contributory factor (Levy et al., 1969; Sturman et al., 1970) . Hypermethioninaemia may also be found in some forms of tyrosinaemia (Scriver et al., 1966) , in severe liver disease (Walshe, 1953; Iber et al., 1957) , and in association with a deficiency of hepatic S-adenosylmethionine synthetase activity (Gout et al., 1977 Blood methionine assay. The method was basically that of Guthrie (1968) . Dried blood spots of 6 4 mm in diameter were punched out of the cards and placed on the surface of an agar plate containing the inhibitor methionine sulphoximine and spores of Bacillus subtilis (strain ATCC-6633). Standard controls which consisted of expired donor bloods containing a range of L-methionine concentrations (1-20 mg/100 ml; 67-1342 ,mol/l) were also included on the plate. Plates were incubated overnight at 370C. The inhibitor suppresses growth of B. subtilis unless methionine is present in sufficient concentrations. The methionine concentration in the blood sample was determined by comparing the diameter of the growth zone near the blood spot with that of standard controls.
Other laboratory investigations. Amino-acids were eluted from blood spots with ethanol (70% by vol. in water), separated by thin-layer chromatography and located on separate layers with ninhydrin and iodoplatinate reagents (Ersser and Smith, 1976) . Amino-acids in plasma and urine were analysed by both thin-layer and quantitative ion-exchange chromatography (Ersser, 1976 accounted for this. The most likely explanation is the change in infant feeding practice which has taken place in the UK. A reduction in the protein content of infant milk formulae, later introduction of solids, and a renewal of interest in breast feeding may all have contributed.
The maximum blood methionine concentrations recorded in boys and girls with transient hypermethioninaemia were similar (boys: mean 12 mg/ 100 ml (805 ,umol/l), gross range 5-20 mg/100 ml (336-1342 Vmol/l); girls: mean 11 mg/100 ml (738 ,mol/l), gross range 7-16 mg/100 ml ,umol/l)). These maximum values tended to occur later in girls than in boys (girls: mean 45 days, gross range 21-87; boys: mean 30 days, gross range 6-75) but the difference was not significant. Differences in the periods between sampling in different individuals and the small number of affected infants suggest that this finding should be interpreted with caution.
Homocystinuria. During the first 3 years of the screening programme homocystinuria was confirmed in 3 infants (Table 2) giving an incidence of one in 88 987 during that period. One required treatment with a low methionine diet, one responded to treatment with pyridoxine, and the 3rd had a transient form which responded to a low-protein diet combined with pyridoxine supplement, and resolved within a year so that no further treatment was required. Table 2 compares the initial blood methionine concentrations in these patients. The infant with the pyridoxine-responsive form had lower initial blood methionine concentrations than the infant who responded only to diet. Levy et al. (1971) observed that an infant with the pyridoxine-responsive form had a normal blood methionine concentration at 4 days. Brenton and Cusworth (1971) found that clinical manifestations were less severe in the pyridoxine-responsive form.
No further cases of homocystinuria have been detected here since 1972; the change in incidence between the periods 1970-72 and 1973-77 is significant (P <0 * 05).
Other conditions which were associated with hypermethioninaemia. A baby boy who was asymptomatic at the time of detection had hypermethioninaemia associated with an acute form of tyrosinaemia (tyrosinosis). The blood methionine concentration was only slightly raised at 6 days but had increased further by 3 weeks. Further investigations showed the presence of tyrosinaemia, tyrosyluria, and a proximal renal tubular defect. Failure to thrive, liver dysfunction, and defective blood coagulation soon became evident and despite attempts to control blood methionine and tyrosine concentrations the child died at 14 weeks. Gjessing and Halvorsen (1965) and Larochelle et al. (1967) concluded that the hypermethioninaemia which occurs in acute tyrosinosis is due to severe liver damage, but this was contested by Gaull et al. (1968) who suggested that an unidentified abnormality caused both the hypermethioninaemia and the tyrosinaemia. Linblad et al. (1977) suggested that some severe forms of hereditary tyrosinaemia may be associated with a fumarylacetoacetase deficiency and that the resulting metabolites, succinyl acetate and succinylacetone, are toxic to the liver and kidneys.
Another baby boy, born in 1970, had a raised blood methionine concentration (about 10 mg/100 ml; 671 ,mol/l) and raised serum alkaline phosphatase, alanine transferase, and aspartate transferase activities which persisted into the 2nd year of life. No other biochemical abnormality was detected and unlike the otherwise similarly affected infants described by Komrower and Robins (1969) he was not anaemic. The child developed normally and the condition resolved spontaneously without treatment or change of diet. (Black, 1971; Shukla et al., 1972; Davies, 1973) . The association of neonatal hypermethioninaemia with a high protein intake had already been recognised (Komrower and Robins, 1969) , and Sturman et al. (1970) suggested that the high methionine:cystine ratio of the protein in cows' milk was inappropriate for human infants. Reports on the possible harmful effects of infantile overnutrition (Taitz, 1971; Menkes et al., 1972; Shukla et al., 1972) may have influenced such feeding practices as the early introduction of solid foods, and may have contributed to the initial reduction in the incidence of neonatal hypermethioninaemia in 1973. Several 'modified' milks with protein concentrations of 1-8 g per 100 ml were introduced in 1973 and 1974. Also in the period from about 1970 to 1972, maternity units began to use infant milk formulae which were accurately diluted and prepacked by the manufacturers.
The apparent disappearance of transient neonatal hypermethioninaemia in 1976 may have been due to the withdrawal of high-protein milks-such as national dried full cream milk-the widespread introduction ofinfant milk preparations witha protein content and casein:lactalbumin ratio approaching that of human breast milk, and to the publication Present-day Practice in Infant Feeding (Department of Health and Social Security, 1974) which put forward official recommendations for changes in infant feeding practice. The reason why the girls Changing incidence of neonatal hypernmethioninaemia 597 but not the boys responded as early as 1973 is uncertain but could be due to a difference in ability to metabolise methionine or to a difference in total milk intake. Whatever the cause these results suggest that the protein intake, or more specifically the methionine intake, of infants decreased in 1973 and decreased further in 1976.
The apparent failure to detect homocystinuria since 1972 coincided with the reduction in the incidence of neonatal hypermethioninaemia. No 'missed' cases of homocystinuria in the areas concerned have yet been brought to our notice but the disease may not be obvious in the early stages. Thus, it appears that the earlier moves away from breast feeding (Newson and Newson, 1962) and the tendency towards infantile overnutrition were conducive to the detection of homocystinuria by neonatal screening programmes which measured blood methionine concentration in early infancy. Ironically, better infant feeding practices necessitate a reassessment of the methods used to detect homocystinuria. Furthermore possible similar effects on the neonatal screening of other inborn errors of amino-acid metabolism should be borne in mind.
These findings, and the studies of Wilcken and Turner (1978) in New South Wales, suggest that the true rate of homocystinuria is greater than that indicated by neonatal screening programmes. Infants with mild forms of the disease are even less likely to be detected. Estimates of the incidence of homocystinuria have varied widely from one area to another. This could be partly attributed to different methods of screening and to different patterns of infant feeding. At present there is no justification for national screening of homocystinuria early in the neonatal period and the reliability of the Guthrie method needs to be carefully reassessed.
The concentration of methionine in blood is normally <67 ,umol/l and the cut-off point of 268 ,imol/l used in the screening programme may now be too high. During a trial period, initially for one year, all infants screened at this centre who have blood methionine concentrations of 2 mg/100 ml (134 ,umol/l) or more will be further investigated. However, recent experience suggests that this procedure will not improve the detection of homocystinuria. Furthermore, Wilcken and Turner (1978) suggest that even including a test for urinary homocystine in a neonatal screening programme at 6 weeks does not ensure detection of the disease.
Our own experience is similar to that described by Whiteman et al. Most infants in the North-western Region are tested between 10 and 14 days after birth (primarily for phenylketonuria) and to date over half a million babies have been screened. The method used is one-dimensional paper chromatography of plasma (Scriver et al., 1964 ) which can detect 6 related amino-acid abnormalities, including hypermethioninaemia (Sardharwalla et al., 1972) . This technique is sufficiently sensitive to detect a plasma methionine concentration of 0 2 mmol/l (2 98 mg/ 100 ml). If plasma methionine concentration is >0-6 mmol/l (>8 9 mg/100 ml) immediate steps are taken to have the baby brought to the metabolic unit for detailed investigations. If, however, on initial screening the plasma methionine is between 0 2 and 0 6 mmol/l the test is repeated after one month. If the repeat test shows a normal pattern no further action is taken, but a persistent abnormality is investigated.
Of 12 babies identified because initial levels of plasma methionine were >0 6 mmol/l, homocystinuria was confirmed in 5 of them, one had galactosaemia with liver damage, one had oc-1-antitrypsin deficiency with liver involvement, and one was found to have bacterial hepatitis after septicaemia. In the other 4 babies in whom raised methionine was associated with raised plasma tyrosine we were able to establish the diagnosis of hereditary tyrosinaemia.
I share the view that some infants with homocystinuria will not be identified by any neonatal screening method designed to detect raised plasma methionine. One baby with homocystinuria, a younger sibling of a known case, did not have a raised level of plasma methionine when tested on the 10th and 17th days after birth, but the level of homocystine in the blood was increased when measured on day 17.
We too have noticed a steady fall in the incidence of transient hypermethioninaemia since 1973 and have seen this trend reflected in the incidence of the other aminoacidaemias. This is shown in the Table. I agree that this decline is probably related to the wider use of low-protein milk formulae but would suggest that the occurrence of some transient aminoacidaemias may be due to temporary immaturity of enzymes necessary in the metabolism of relevant amino-acids. Amino-acids 1972 Amino-acids 1973 Amino-acids 1974 Amino-acids 1975 Amino-acids 1976 Amino-acids 1977 Amino-acids 1978 
